Virus filtration is mainly used to maintain a pathogen such as bacteria, virus, and microbe’s free environment. Presence of pathogens in labs, and biotechnology industries lead to the contamination of water, air, and biotheraputics. Virus filtration maintains the environment and products safety. It also ensures that the products manufactured are of high grade. Virus filtration is an important step in the biopharmaceutical industry, as it ensures that the products are adequately purified to be fit for consumption. Virus filtration also helps to optimize process economics and prevents the loss of valuable products. They are widely used in application such as air purification, water purification, medical devices, stem cell products and others. Usually, these pathogens make the environment contaminated which is not good for health. They are usually done in the end of purification step. Filtration and chromatography are the technologies which are used in virus filtration.
Request for sample here: “Virus Filtration Market”
Virus filtration is a virus clearance technology, which assures most reliable, robust and stable virus retension even under challenging process conditions such as pressure interruptions. Virus filtration is considered to be one of the most significant and crucial procedure in pharmaceutical industry. Besides optimizing the process economics it helps in ensuring efficient purification of the sample under test and purification. Nowadays, biological drugs such as biosimilars and recombinant vaccines require advanced GMP’s to fall it into all the aspects of drug approval. As the pharmaceutical industry is advancing, many potential biological therapeutic drugs are being introduced to the market. These biological drugs are prone to viral contamination which could lead to huge economic loss to a manufacturer. The virus filters provide an advanced solution to the viral contamination. It is being widely adopted in the production of biological drugs, medical device, tissue and tissue products, cellular and gene therapy products.
The “Global Virus Filtration Market” is accounted for $2.22 billion in 2016 and expected to grow at a CAGR of 13.7% to reach $5.46 billion by 2023.
Qiagen and Merck Millipore are two of the widely known companies for reagents and kits for virus filtration. The samples used in the biopharmaceuticals production may include blood, plasma, serum, or bodily fluids, or any monoclonal antibody and recombinant proteins. Even several biologic and pharmaceutical-based companies are opting in to invest more in R&D of vaccines, protein therapeutics, blood products, cellular therapy products, gene therapy products, tissue products, and stem cell products. The demand for these kits and reagents provide ample opportunities to the market. The main factors attributing to the development of the virus filtration market are increasing R&D spending, growth in the biopharmaceutical industry, and adoption of single-use technologies. Also, factors such as the increasing prevalence of chronic diseases are contributing to the growth of the market.
Request for customization here: “Virus Filtration Market”
The increasing prevalence of chronic diseases, including cancer, diabetes, and autoimmune disorders, are anticipated to propel the demand for biologics. The kits, reagents, and consumables segment serves as an important category in the virus filtration market. The reagents help to reduce the potential of iatrogenic transmission of pathogenic viruses. In the process evaluation, the reagents help to identify the virus that is likely to contaminate the cell substrate or any other reagents or materials used in the process.
For more information fill in the Inquiry form at: “Virus Filtration Market”
North America is anticipated to dominate the virus filtration market, throughout the forecast period. This is due to the increasing incidence of diseases and the presence of more number of pharmaceutical companies in the region. Additionally, in recent years, there has been increased regulatory scrutiny of incidents related to adventitious viruses in manufacturing processes. In the North American region, the United States holds the largest market share. The well-established biotechnology and biopharmaceutical industry in the United States has spurred the demand for advanced viral clearance products for R&D and biologics production in this region. Owing to the increased research and development activities of biopharmaceutical companies, the demand for biologics is expected to drive the viral filtration market, during the forecast period. Growth of the North American viral filtration market can also be attributed to the growth of biopharmaceutical industry. Furthermore, the regional market growth can be attributed to the presence of key manufacturers in the region. In addition, the augmented demand for filtration products also supported the growth of virus filtration market in the region.
0 Comments